Actively hiring
Genomics & Genetic Testing
Molecular Diagnostics
Diagnostic Tests & IVD
As featured in
View 2 jobs
Claim pageClaim
Follow
Overview
Connections
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
Overview
Genecast Innotech is the Singapore entity of Genecast, a precision oncology company working on molecular diagnostics, translational research and innovation. It supports cancer detection, genomic profiling, therapy selection and disease monitoring using NGS, liquid biopsy and multi-omics technologies, and it is hiring an NGS laboratory technologist. The company is based in Singapore.
News
Report
March 25, 2025 Dynamic ctDNA informs whole-course postoperative precise management of NSCLC (LUNGCA study)
Read more
Report
February 27, 2025 An Expanding Universe of Mutational Signatures and Its Rapid Evolution in Single-Stranded RNA Viruse
Read more
Report
Neoadjuvant pyrotinib and trastuzumab in HER2-positive breast cancer with no early response (NeoPaTHer): efficacy, safety and biomarker analysis of a prospective, multicentre, response-adapted study
The potential benefits of pyrotinib for patients with trastuzumab-insensitive, HER2-positive early-stage breast cancer remain unclear. This prospective, multicentre, response-adapted study evaluated the efficacy and safety of adding pyrotinib to the neoad
Read more
Report
December 25, 2024 AYVM to AYMM Transition on HER2 Exon 20 Insertion Induces Tyrosine Kinase Inhibitor Resistance in NSCLC
Read more
Report
Spatial interactions of immune cells as potential predictors to efficacy of toripalimab plus chemotherapy in locally advanced or metastatic pancreatic ductal adenocarcinoma: a phase Ib/II trial
Advanced pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis. Immunotherapy alone offers limited efficacy, but it is still unknown whether its combination with chemotherapy could offer synergistic anti-tumor effects. This phase Ib/II study eval
Read more
Report
Tislelizumab plus cetuximab and irinotecan in refractory microsatellite stable and RAS wild-type metastatic colorectal cancer: a single-arm phase 2 study
Immunotherapy confers little to no benefit in the treatment of microsatellite stable (MSS) metastatic colorectal cancer (mCRC). Mechanistic insights suggested that epidermal growth factor receptor (EGFR) antibody plus irinotecan might augment the tumor im
Read more
Report
Clinical efficacy and identification of factors confer resistance to afatinib (tyrosine kinase inhibitor) in EGFR-overexpressing esophageal squamous cell carcinoma
Epidermal growth factor receptor (EGFR) is reportedly overexpressed in most esophageal squamous cell carcinoma (ESCC) patients, but anti-EGFR treatments offer limited survival benefits. Our preclinical data showed the promising antitumor activity of afati
Read more
Report
Tech stack
Technologies named in job postings at Genecast over the last 12 months, by layer, with the share of postings for each.
Technologies in use
3
Postings analysed
2
Stack modernity
50/100
Practices & domains
Next-Generation Sequencing
GLP
PCR
Sign in to see how your skills match this stack
Sign In
Salary insights
Compensation ranges based on this company's open jobs
Median
$54k
Typical range
$47k – $61k
Open positions
2
2
Jobs
Junior
50%
Senior
50%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Junior | 1 | $47k | $47k |
| Senior | 1 | $61k | $61k |
Highest paying role
Senior NGS Laboratory Technician / NGS Laboratory Supervisor
$61k
Normalized to USD per year
Growth
Hiring Momentum
28/100
Slowing
Open positions
2
0 opened / 0 closed in 30 days
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Field & Service
100% ▲
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Singapore
Singapore
Singapore
HQ
1 open roles 1 posted in 90 days $47k Avg Salary
hires for Field & Service
Jobs
$45k – $61k per year (gross) · In office · Full-Time · 3+ years exp · Singapore
Next-Generation Sequencing
GLP
Apply
$38k – $47k per year (gross) · In office · Full-Time · 1+ year exp · Singapore
PCR
Next-Generation Sequencing
Apply
